Metabolic Imaging of Ischemic Stroke: The Present and Future

References

1. 1.↵
   1. Astrup J,
   2. Siesjo BK,
   3. Symon L

   . Thresholds in cerebral ischemia: the ischemic penumbra. Stroke 1981;12:723–5

   FREE Full Text
2. 2.↵
   1. Furlan M,
   2. Marchal G,
   3. Viader F,
   4. et al

   . Spontaneous neurological recovery after stroke and the fate of the ischemic penumbra. Ann Neurol 1996;40:216–26

   CrossRefPubMedWeb of Science
3. 3.↵
   National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581–7

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Heiss WD,
   2. Huber M,
   3. Fink GR,
   4. et al

   . Progressive derangement of periinfarct viable tissue in ischemic stroke. J Cereb Blood Flow Metab 1992;12:193–203

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Marchal G,
   2. Beaudouin V,
   3. Rioux P,
   4. et al

   . Prolonged persistence of substantial volumes of potentially viable brain tissue after stroke: a correlative PET-CT study with voxel-based data analysis. Stroke 1996;27:599–606

   Abstract/FREE Full Text
6. 6.↵
   1. Marchal G,
   2. Serrati C,
   3. Rioux P,
   4. et al

   . PET imaging of cerebral perfusion and oxygen consumption in acute ischaemic stroke: relation to outcome. Lancet 1993;341:925–7

   CrossRefPubMedWeb of Science
7. 7.↵
   1. Heiss WD,
   2. Kracht L,
   3. Grond M,
   4. et al

   . Early [(11)C]Flumazenil/H(2)O positron emission tomography predicts irreversible ischemic cortical damage in stroke patients receiving acute thrombolytic therapy. Stroke 2000;31:366–9

   Abstract/FREE Full Text
8. 8.↵
   1. Read SJ,
   2. Hirano T,
   3. Abbott DF,
   4. et al

   . Identifying hypoxic tissue after acute ischemic stroke using PET and 18F-fluoromisonidazole. Neurology 1998;51:1617–21

   CrossRef
9. 9.↵
   1. Rojas S,
   2. Martin A,
   3. Pareto D,
   4. et al

   . Positron emission tomography with C-11-flumazenil in the rat shows preservation of binding sites during the acute phase after 2h-transient focal ischemia. Neuroscience 2011;182:208–16

   CrossRefPubMed
10. 10.↵
    1. Spratt NJ,
    2. Donnan GA,
    3. McLeod DD,
    4. et al

    . ‘Salvaged’ stroke ischaemic penumbra shows significant injury: studies with the hypoxia tracer FMISO. J Cereb Blood Flow Metab 2011;31:934–43

    CrossRefPubMed
11. 11.↵
    1. Grond M,
    2. Von Kummer R,
    3. Sobesky J,
    4. et al

    . Early x-ray hypoattenuation of brain parenchyma indicates extended critical hypoperfusion in acute stroke. Stroke 2000;31:133–9

    Abstract/FREE Full Text
12. 12.↵
    1. Muir KW,
    2. Baird-Gunning J,
    3. Walker L,
    4. et al

    . Can the ischemic penumbra be identified on noncontrast CT of acute stroke? Stroke 2007;38:2485–90

    Abstract/FREE Full Text
13. 13.↵
    1. Chalela JA,
    2. Kidwell CS,
    3. Nentwich LM,
    4. et al

    . Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison. Lancet 2007;369:293–98

    CrossRefPubMedWeb of Science
14. 14.↵
    1. Guadagno JV,
    2. Warburton EA,
    3. Jones PS,
    4. et al

    . How affected is oxygen metabolism in DWI lesions? A combined acute stroke PET-MR study. Neurology 2006;67:824–9

    CrossRef
15. 15.↵
    1. Kidwell CS,
    2. Saver JL,
    3. Mattiello J,
    4. et al

    . Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging. Ann Neurol 2000;47:462–9

    CrossRefPubMedWeb of Science
16. 16.↵
    1. Freeman JW,
    2. Luby M,
    3. Merino JG,
    4. et al

    . Negative diffusion-weighted imaging after intravenous tissue-type plasminogen activator is rare and unlikely to indicate averted infarction. Stroke 2013;44:1629–34

    Abstract/FREE Full Text
17. 17.↵
    1. Thomalla G,
    2. Rossbach P,
    3. Rosenkranz M,
    4. et al

    . Negative fluid-attenuated inversion recovery imaging identifies acute ischemic stroke at 3 hours or less. Ann Neurol 2009;65:724–32

    CrossRefPubMed
18. 18.↵
    1. Thomalla G,
    2. Ebinger M,
    3. Fiehler J,
    4. et al

    . EU-funded treatment study: WAKE-UP: a randomized, placebo-controlled MRI-based trial of thrombolysis in wake-up stroke. Nervenarzt 2012;83:1241–51

    CrossRefPubMed
19. 19.↵
    1. Schlaug G,
    2. Benfield A,
    3. Baird AE,
    4. et al

    . The ischemic penumbra: operationally defined by diffusion and perfusion MRI. Neurology 1999;53:1528–37

    CrossRef
20. 20.↵
    1. Dani KA,
    2. Thomas RGR,
    3. Chappell FM,
    4. et al

    . Systematic review of perfusion imaging with computed tomography and magnetic resonance in acute ischemic stroke: heterogeneity of acquisition and postprocessing parameters a translational medicine research collaboration multicentre acute stroke imaging study. Stroke 2012;43:563–66

    Abstract/FREE Full Text
21. 21.↵
    1. Dani KA,
    2. Thomas RGR,
    3. Chappell FM,
    4. et al

    . Computed tomography and magnetic resonance perfusion imaging in ischemic stroke: definitions and thresholds. Ann Neurol 2011;70:384–401

    CrossRefPubMed
22. 22.↵
    1. Olivot JM,
    2. Mlynash M,
    3. Thijs VN,
    4. et al

    . Optimal Tmax threshold for predicting penumbral tissue in acute stroke. Stroke 2009;40:469–75

    Abstract/FREE Full Text
23. 23.↵
    1. Wintermark M,
    2. Flanders AE,
    3. Velthuis B,
    4. et al

    . Perfusion-CT assessment of infarct core and penumbra: receiver operating characteristic curve analysis in 130 patients suspected of acute hemispheric stroke. Stroke 2006;37:979–85

    Abstract/FREE Full Text
24. 24.↵
    1. Gideon P,
    2. Henriksen O,
    3. Sperling B,
    4. et al

    . Early time course of N-acetylaspartate, creatine and phosphocreatine, and compounds containing choline in the brain after acute stroke: a proton magnetic resonance spectroscopy study. Stroke 1992;23:1566–72

    Abstract/FREE Full Text
25. 25.↵
    1. Saunders DE,
    2. Howe FA,
    3. van den Boogaart A,
    4. et al

    . Continuing ischemic damage after acute middle cerebral artery infarction in humans demonstrated by short-echo proton spectroscopy. Stroke 1995;26:1007–13

    Abstract/FREE Full Text
26. 26.↵
    1. Munoz Maniega S,
    2. Cvoro V,
    3. Chappell FM,
    4. et al

    . Changes in NAA and lactate following ischemic stroke: a serial MR spectroscopic imaging study. Neurology 2008;71:1993–99

    CrossRef
27. 27.↵
    1. Singhal AB,
    2. Ratai E,
    3. Benner T,
    4. et al

    . Magnetic resonance spectroscopy study of oxygen therapy in ischemic stroke. Stroke 2007;38:2851–4

    Abstract/FREE Full Text
28. 28.↵
    1. Dani KA,
    2. An L,
    3. Henning EC,
    4. et al

    . Multivoxel MR spectroscopy in acute ischemic stroke comparison to the stroke protocol MRI. Stroke 2012;43:2962–67

    Abstract/FREE Full Text
29. 29.↵
    1. Holmes WM,
    2. Lopez-Gonzalez MR,
    3. Gallagher L,
    4. et al

    . Novel MRI detection of the ischemic penumbra: direct assessment of metabolic integrity. NMR Biomed 2012;25:295–304

    CrossRefPubMed
30. 30.↵
    1. An L,
    2. Dani KA,
    3. Shen J,
    4. et al

    . Pilot results of in vivo brain glutathione measurements in stroke patients. J Cereb Blood Flow Metab 2012;32:2118–21

    CrossRefPubMed
31. 31.↵
    1. Zhu X,
    2. Zhang Y,
    3. Wiesner H,
    4. et al

    . In vivo measurement of CBF using (17) O NMR signal of metabolically produced H(2) (17) O as a perfusion tracer. Magn Reson Med 2013;70:309–14

    CrossRefPubMed
32. 32.↵
    1. Zhu X-H,
    2. Chen JM,
    3. Tu T-W,
    4. et al

    . Simultaneous and noninvasive imaging of cerebral oxygen metabolic rate, blood flow and oxygen extraction fraction in stroke mice. Neuroimage 2013;64:437–47

    CrossRefPubMed
33. 33.↵
    1. Atkinson IC,
    2. Sonstegaard R,
    3. Pliskin NH,
    4. et al

    . Vital signs and cognitive function are not affected by 23-sodium and 17-oxygen magnetic resonance imaging of the human brain at 9.4 T. J Magn Reson Imaging 2010;32:82–87

    CrossRefPubMed
34. 34.↵
    1. Atkinson IC,
    2. Thulborn KR

    . Feasibility of mapping the tissue mass corrected bioscale of cerebral metabolic rate of oxygen consumption using 17-oxygen and 23-sodium MR imaging in a human brain at 9.4 T. Neuroimage 2010;51:723–33

    CrossRefPubMed
35. 35.↵
    1. Thulborn KR,
    2. Gindin TS,
    3. Davis D,
    4. et al

    . Comprehensive MR imaging protocol for stroke management: tissue sodium concentration as a measure of tissue viability in nonhuman primate studies and in clinical studies. Radiology 1999;213:156–66

    CrossRefPubMedWeb of Science
36. 36.↵
    1. Wetterling F,
    2. Ansar S,
    3. Handwerker E

    . Sodium-23 magnetic resonance imaging during and after transient cerebral ischemia: multinuclear stroke protocols for double-tuned Na-23/H-1 resonator systems. Physics Med Biol 2012;57:6929–46

    CrossRefPubMed
37. 37.↵
    1. Heiler PM,
    2. Langhauser FL,
    3. Wetterling F,
    4. et al

    . Chemical shift sodium imaging in a mouse model of thromboembolic stroke at 9.4 T. J Magn Reson Imaging 2011;34:935–40

    CrossRefPubMed
38. 38.↵
    1. Hussain MS,
    2. Stobbe RW,
    3. Bhagat YA,
    4. et al

    . Sodium imaging intensity increases with time after human ischemic stroke. Ann Neurol 2009;66:55–62

    CrossRefPubMed
39. 39.↵
    1. Tsang A,
    2. Stobbe RW,
    3. Asdaghi N,
    4. et al

    . Relationship between sodium intensity and perfusion deficits in acute ischemic stroke. J Magn Reson Imaging 2011;33:41–47

    CrossRefPubMed
40. 40.↵
    1. Morita N,
    2. Harada M,
    3. Uno M,
    4. et al

    . Ischemic findings of T2*-weighted 3-Tesla MRI in acute stroke patients. Cerebrovasc Dis 2008;26:367–75

    CrossRefPubMed
41. 41.↵
    1. Tamura H,
    2. Hatazawa J,
    3. Toyoshima H,
    4. et al

    . Detection of deoxygenation-related signal change in acute ischemic stroke patients by T2*-weighted magnetic resonance imaging. Stroke 2002;33:967–71

    Abstract/FREE Full Text
42. 42.↵
    1. Wardlaw JM,
    2. von Heijne A

    . Increased oxygen extraction demonstrated on gradient echo (T2*) imaging in a patient with acute ischaemic stroke. Cerebrovasc Dis 2006;22:456–58

    CrossRefPubMed
43. 43.↵
    1. Geisler BS,
    2. Brandhoff F,
    3. Fiehler J,
    4. et al

    . Blood-oxygen-level-dependent MRI allows metabolic description of tissue at risk in acute stroke patients. Stroke 2006;37:1778–84

    Abstract/FREE Full Text
44. 44.↵
    1. Donswijk ML,
    2. Jones PS,
    3. Guadagno JV,
    4. et al

    . T2*-weighted MRI versus oxygen extraction fraction PET in acute stroke. Cerebrovasc Dis 2009;28:306–13

    CrossRefPubMed
45. 45.↵
    1. Santosh C,
    2. Brennan D,
    3. McCabe C,
    4. et al

    . Potential use of oxygen as a metabolic biosensor in combination with T2*-weighted MRI to define the ischemic penumbra. J Cereb Blood Flow Metab 2008;28:1742–53

    CrossRefPubMed
46. 46.↵
    1. Robertson CA,
    2. McCabe C,
    3. Gallagher L,
    4. et al

    . Stroke penumbra defined by an MRI-based oxygen challenge technique, 1: validation using [(14)C]2-deoxyglucose autoradiography. J Cereb Blood Flow Metab 2011;31:1778–87

    CrossRefPubMed
47. 47.↵
    1. Robertson CA,
    2. McCabe C,
    3. Gallagher L,
    4. et al

    . Stroke penumbra defined by an MRI-based oxygen challenge technique, 2: validation based on the consequences of reperfusion. J Cereb Blood Flow Metab 2011;31:1788–98

    CrossRefPubMed
48. 48.↵
    1. Shen Q,
    2. Huang S,
    3. Du F,
    4. et al

    . Probing ischemic tissue fate with BOLD fMRI of brief oxygen challenge. Brain Res 2011;1425:132–41

    CrossRefPubMed
49. 49.↵
    1. Dani KA,
    2. Santosh C,
    3. Brennan D,
    4. et al

    . T2*-weighted magnetic resonance imaging with hyperoxia in acute ischemic stroke. Ann Neurol 2010;68:37–47

    CrossRefPubMed
50. 50.↵
    1. Yablonskiy DA,
    2. Haacke EM

    . Theory of NMR signal behavior in magnetically inhomogeneous tissues: the static dephasing regime. Magn Reson Med 1994;32:749–63

    CrossRefPubMedWeb of Science
51. 51.↵
    1. An H,
    2. Lin W

    . Quantitative measurements of cerebral blood oxygen saturation using magnetic resonance imaging. J Cereb Blood Flow Metab 2000;20:1225–36

    PubMedWeb of Science
52. 52.↵
    1. Lee JM,
    2. Vo KD,
    3. An H,
    4. et al

    . Magnetic resonance cerebral metabolic rate of oxygen utilization in hyperacute stroke patients. Ann Neurol 2003;53:227–32

    CrossRefPubMedWeb of Science
53. 53.↵
    1. Lin W,
    2. An H,
    3. Ford AL,
    4. et al

    . MR imaging of oxygen extraction and neurovascular coupling. Stroke 2013;44:S61–64

    FREE Full Text
54. 54.↵
    1. Ward KM,
    2. Aletras AH,
    3. Balaban RS

    . A new class of contrast agents for MRI based on proton chemical exchange dependent saturation transfer (CEST). J Magn Reson 2000;143:79–87

    CrossRefPubMedWeb of Science
55. 55.↵
    1. Zhou JY,
    2. Payen JF,
    3. Wilson DA,
    4. et al

    . Using the amide proton signals of intracellular proteins and peptides to detect pH effects in MRI. Nat Med 2003;9:1085–90

    CrossRefPubMedWeb of Science
56. 56.↵
    1. Sun PZ,
    2. Cheung JS,
    3. Wang E,
    4. et al

    . Association between pH-weighted endogenous amide proton chemical exchange saturation transfer MRI and tissue lactic acidosis during acute ischemic stroke. J Cereb Blood Flow Metab 2011;31:1743–50

    CrossRefPubMed
57. 57.↵
    1. Sun PZ,
    2. Zhou J,
    3. Sun W,
    4. et al

    . Detection of the ischemic penumbra using pH-weighted MRI. J Cereb Blood Flow Metab 2007;27:1129–36

    CrossRefPubMed
58. 58.↵
    1. Jokivarsi KT,
    2. Hiltunen Y,
    3. Tuunanen PI,
    4. et al

    . Correlating tissue outcome with quantitative multiparametric MRI of acute cerebral ischemia in rats. J Cereb Blood Flow Metab 2010;30:415–27

    CrossRefPubMed
59. 59.↵
    1. Zhao X,
    2. Wen Z,
    3. Huang F,
    4. et al

    . Saturation power dependence of amide proton transfer image contrasts in human brain tumors and strokes at 3 T. Magn Reson Med 2011;66:1033–41

    CrossRefPubMed